Iadarola M J, Gale K
Science. 1982 Dec 17;218(4578):1237-40. doi: 10.1126/science.7146907.
Localization of the anatomic substrate for anticonvulsant activity mediated by gamma-aminobutyric acid (GABA) was examined using intracerebral injections of GABA agonists. Blockade of tonic hindlimb extension in the maximal electroshock test and blockade of tonic and clonic seizures produced by pentylenetetrazole and bicuculline were obtained by elevating GABA in the ventral midbrain tegmentum. Elevation of GABA in forebrain and hindbrain areas had no effect on convulsant activity. Blockade of tonic and clonic seizures was also obtained after microinjections of the direct GABA receptor agonist, muscimol, into the midbrain. The substantia nigra was identified as the critical midbrain site for GABA-mediated anticonvulsant activity. Local injection of GABA agonists into the midbrain provided seizure protection without a widespread augmentation of GABA-mediated activity throughout the brain and without impairing either alertness or motor function. Synapses in the substantia nigra appear to represent an important control mechanism for inhibiting the propagation of generalized convulsions.
通过脑内注射γ-氨基丁酸(GABA)激动剂,研究了介导抗惊厥活性的解剖学底物的定位。在最大电休克试验中,通过提高腹侧中脑被盖区的GABA水平,可阻断强直性后肢伸展,并阻断戊四氮和荷包牡丹碱引起的强直性和阵挛性惊厥。前脑和后脑区域的GABA水平升高对惊厥活性没有影响。将直接GABA受体激动剂蝇蕈醇微量注射到中脑后,也可阻断强直性和阵挛性惊厥。黑质被确定为GABA介导的抗惊厥活性的关键中脑部位。向中脑局部注射GABA激动剂可提供癫痫保护,而不会在全脑广泛增强GABA介导的活性,也不会损害警觉性或运动功能。黑质中的突触似乎代表了一种重要的控制机制,用于抑制全身性惊厥的传播。